Korro Bio KRRO
NASDAQ KRRO
$14.41 -1.32 (-8.39%)
At close: Nov 11, 2026 · 4:00 PM EST

Korro Bio (KRRO) EV to CFO (2019 - 2020)

Updated

Korro Bio's EV to CFO came in at 1433.08 for Q2 2020, up 62.1% from the prior quarter.

Analysis

Korro Bio (KRRO) EV to CFO (2019 - 2020) Analysis & Trends

Over the trailing twelve months to Jun 30, 2020, Korro Bio reported EV to CFO of 1409.72; for FY2019, it was 215.21.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Korro Bio 281.05 Mn -128.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 21.07
Mar 31, 2020 17.66
Dec 31, 2019 -1.92
API Access

Korro Bio EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=KRRO&period=max&api_key=YOUR_API_KEY